Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches

19Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tumor heterogeneity, a key hallmark of hepatocellular carcinomas (HCCs), poses a significant challenge to developing effective therapies or predicting clinical outcomes in HCC. Recent advances in next-generation sequencing-based multi-omic and single cell analysis technologies have enabled us to develop high-resolution atlases of tumors and pull back the curtain on tumor heterogeneity. By combining multiregion targeting sampling strategies with deep sequencing of the genome, transcriptome, epigenome, and proteome, several studies have revealed novel mechanistic insights into tumor initiation and progression in HCC. Advances in multiparametric immune cell profiling have facilitated a deeper dive into the biological complexity of HCC, which is crucial in this era of immunotherapy. Moreover, studies using liquid biopsy have demonstrated their potential to circumvent the need for tissue sampling to investigate heterogeneity. In this review, we discuss how multi-omic and single-cell sequencing technologies have advanced our understanding of tumor heterogeneity in HCC.

References Powered by Scopus

Cancer statistics, 2020

16809Citations
N/AReaders
Get full text

Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

4718Citations
N/AReaders
Get full text

A framework for advancing our understanding of cancer-associated fibroblasts

2360Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives

58Citations
N/AReaders
Get full text

Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials

47Citations
N/AReaders
Get full text

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

41Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dhanasekaran, R. (2021). Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches. Seminars in Liver Disease, 41(1), 9–18. https://doi.org/10.1055/s-0040-1722261

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

50%

Researcher 2

50%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

50%

Agricultural and Biological Sciences 2

25%

Medicine and Dentistry 2

25%

Save time finding and organizing research with Mendeley

Sign up for free